What is ABECMA? ABECMA (idecabtagene vicleucel) is a prescription medicine for the treatment of multiple myeloma in patients who have received at least three kinds of treatment regimens that have not worked or have stopped working. ABECMA is a medicine made from your own white blood cells; the cells are genetically modified to recognize and attack your multiple myeloma cells.
This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.
ABECMA® is now available if you've received at least 2 kinds of treatment regimens that include a therapy from each of these drug classes: an immunomodulatory agent, a proteasome inhibitor, and an
It's never too early to talk to your doctor about a one-time* infusion of ABECMA a CAR T cell therapy made from your own immune cells to fight multiple myeloma.†
See if ABECMA may be right for you >*The treatment process includes blood collection, CAR T cell creation, administration, and adverse event monitoring.
†ABECMA can also target normal, healthy cells.
CAR=chimeric antigen receptor.
My advice to others is to learn about your treatment
options as early as you can. That way, you’ll be prepared.
— Mary, treated with ABECMA
How ABECMA
works
ABECMA CAR T cell therapy
is created just for you using
cells from your own body.
Don't wait to talk to your doctor about ABECMA
ABECMA offers unlimited supply, no wait lists, and more locations closer to home.
FIND A LOCATION NEAR YOU